Blind controlled trial of dextran 40 in the treatment of ischemic stroke

Completed

Phase N/A Results

Summary of Purpose

To test the potential benefits of dextran 40 in patients with ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 9 November 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • M.R.C., Pharmacia Limited.

Trial Design

Randomized, bind, controlled trial of 100 patients at 5 centers.

Contacts

Not available